Are fish oils an effective therapy in mental illness - An analysis of the data

Acta Psychiatrica Scandinavica

Volumn 102, Issue 1, 2000, Pages 3-11

  Maidment, Ian D ^a  

^a NORFOLK AND SUFFOLK NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bipolar disorder; Depression; Fatty acids; Fish oils; Schizophrenia

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID;

CLINICAL RESEARCH; DATA ANALYSIS; DRUG EFFICACY; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL LITERATURE; MENTAL DISEASE; NEGATIVE SYNDROME; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

BIPOLAR DISORDER; DEPRESSION; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; MENTAL DISORDERS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0034084871     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2000.102001003.x     Document Type: Review

References (40)

1. 1. INMAN K. Is fish oil the cure for schizophrenia? Independent 1998;26 May:17.
2. 2. Anonymous. 1999; http://www.schizophrenia.com.
3. 3. Anonymous. 1999; http://www.shef.ac.uk/uni/projects/omega3/index.htm.
4. 4. KOLETZKO B. Fats for brains. Eur J Clin Nutr 1992;46: 551-562.
5. 5. MAES M, SMITH R, CHRISTOPHE A, COSYNS P, DESNYDER R, MELTZER H. Fatty acid composition in major depression: depressed w3 fractions in cholesteryl esters and increased C20:4w6/C20:5w3 ratio in cholesteryl esters and phospholipids. J Affect Disord 1996;38:35-46.
6. 6. ROCHE HM. Unsaturated fatty acids. Proc Nutr Soc 1999; 58:397-401.
7. 7. EDWARDS R, PEET M, SHAY J, HORROBIN D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998;48: 149-155.
8. 8. HORROBIN DF. The relationship between schizophrenia and essential fatty acids and eicosanoid metabolism. Prostaglandins Leukot Essent Fatty Acids 1992;46:71-77.
9. 9. HORROBIN DF, GLEN AIM, VADDADI K. The membrane hypothesis of schizophrenia. Schizophr Res 1994;13:195-207.
10. 10. PEET M, EDWARDS RW. Lipids, depression and physical diseases. Curr Opin Psychiatry 1997;10:477-480.
11. 11. ADAMS PB, LAWSON S, SANIGORSKI A, SINCLAIR AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996;31(Suppl.3):S157-S161.
12. 12. HIBBELIN JR. Fish consumption and major depression (Letter). Lancet 1998;351:1213.
13. 13. LANDS WEM, LIBELI B, MORRIS A et al. Maintenance of lower proportions of n-6 eicosanoid precursors in phospholipids of human plasma in response to added n-3 fatty acids. Biochim Biophys Acta 1992;1180:147-162.
14. 14. PEET M, MURPHY B, SHAY J, HORROBIN D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998;43:315-319.
15. 15. MAES M, CHRISTOPHE A, DELANGHE J, AITAMURA C, NEELS H, MELIZER HY. Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999;85:275-291.
16. 16. ELLIS FR, SANDERS TAB. Long chain polyunsaturated fatty acids in endogenous depression. J Neurol Neurosurg Psychiatry 1977;40:168-169.
17. 17. FEHILY AMA, BOWEY OAM, ELLIS FR, MEADE BW, DICKERSON JWT. Plasma and erythrocyte membrane long chain polyunsaturated fatty acids in endogenous depression. Neurochem Int 1981;3:37-42.
18. 18. BOSCH X. Fish consumption and depression (Letter). Lancet 1998;352:71-72.
19. 19. HORROBIN DF, BENNETT CN. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids 1999;60:217-234.
20. 20. STOLL AL, SEVERUS E. Mood stabilisers: shared mechanisms of action at post-synaptic signal transduction and kindling processes. Harvard Rev Psychiatry 1996;4:77-89.
21. 21. SPERLING RI, BENINCASO AI, KNOELL CT, LARKIN JK, AUSTEN KF, ROBINSON DR. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 1993;91:651-660.
22. 22. STOLL AL, SEVERUS WE, FREEMAN MP et al. Omega-3 fatty acids in bipolar disorder- a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56:407-412.
23. 23. CALABRESE JR, RAPPORT DJ, SHELTON MD. Fish oils and bipolar disorder- a promising but untested treatment. Arch Gen Psychiatry 1999;56:413-414.
24. 24. STOLL AL, MARANGELL LB. In Reply to the Commentary. Arch Gen Psychiatry 1999;56:415-416.
25. 25. HORROBIN DF. Schizophrenia as a prostaglandin deficiency disease. Lancet 1977;1:936-937.
26. 26. VADDADI KS, COURTNEY T, GILLEARD CJ, MANKU MS, HORROBIN DF. A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia. Psychiatry Res 1989;27:313-323.
27. 27. HORROBIN DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopment concept of schizophrenia. Schizophrenia Res 1998;30:193-208.
28. 28. HORROBIN DF, BENNETT CN. New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 1999;60:141-167.
29. 29. HORROBIN DF. Lipids and schizophrenia (Letter). Br J Psychiatry 1999;175:88.
30. 30. PURI BK, STEINER R, RICHARDSON AJ. Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid. Arch Gen Psychiatry 1998;55:188-189.
31. 31. CHRISTENSEN O, CHRISTENSEN E. Fat consumption and schizophrenia. Acta Psychiatr Scand 1988;78:587-591.
32. 32. MELLOR JE, LAUGHARNE JDE, PEET M. Omega-3 fatty acid supplementation in schizophrenic patients. Hum Psychopharmacol 1996;11:39-46.
33. 33. LAUGHARNE JDE, MELLOR JE, PEET M. Fatty acids and schizophrenia. Lipids 1996;31(Suppl.3):S163-S165.
34. 34. GLEN AIM, GLEN EMT, HORROBIN DF et al. A red cell mem-brane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophr Res 1994; 12:53-61.
35. 35. HORROBIN DF, MANKU MS, HILLMAN H, GLEN AIM. Fatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatry 1991;30:795-805.
36. 36. YAO JK, VAN KAMMEN DP, WELKER JA. Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition. Schizophr Res 1994;13:217-226.
37. 37. NILSSON A, HORROBIN DF, ROSENGREN A, WALLER L, ADLERBERTH A, WILHELMSEN L. Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933. Prostaglandins Leukot Essent Fatty Acids 1996;55:83-87.
38. 38. SHAH S, RAMCHAND CN, PEET M. Eicosapentaenoic acid (EPA) as an adjunct to neuroleptic therapy in the treatment of schizophrenia. Presented at the 9th Schizophrenia Winter Workshop, Davos, 7-13 February 1998.
39. 39. MELLOR JE, PEET M. Double-blind, placebo-controlled, trial of omega-3 fatty acids as an adjunct to the treatment of schizophrenia. Presented at the 9th Schizophrenia Winter Workshop, Davos, 7-13 February 1998.
40. 40. GLEN AIM, COOPER SJ, RYBAKOWSKI J, VADDADI K, BRAYSHAW N, HORROBIN DF. Membrane fatty acids, niacin flushing and clinical parameters. Prostaglandins Leukot Essent Fatty Acids 1996;55:9-15.